The Roles Of Academia, Rare Diseases, And Repurposing In The Development Of The Most Transformative Drugs
- 1 February 2015
- journal article
- Published by Health Affairs Publishing, LLC in Health Affairs
- Vol. 34 (2) , 286-293
Abstract
Transformative drugs, defined as pharmaceuticals that are both innovative and have groundbreaking effects on patient care, are the “holy grail” of drug research and development. The sources of drug innovation are often debated, with pharmaceutical manufacturers arguing that high drug prices support innovative output from their sector. We studied the developmental histories of twenty-six drugs or drug classes approved by the Food and Drug Administration between 1984 and 2009 that were judged by expert physicians to be transformative (in two cases, the first drug in a transformative class was approved before 1984). Most of the twenty-six were first approved early in the study period; only four were approved in 2000 or later. Many were based on discoveries made by academic researchers who were supported by federal government funding. Others were jointly developed in both publicly funded and commercial institutions; the fewest number of drugs had originated solely within pharmaceutical industry research progr...Keywords
This publication has 25 references indexed in Scilit:
- Where do new medicines originate from in the EU?Nature Reviews Drug Discovery, 2014
- Defining “Innovativeness” in Drug Development: A Systematic ReviewClinical Pharmacology & Therapeutics, 2013
- The most transformative drugs of the past 25 years: a survey of physiciansNature Reviews Drug Discovery, 2013
- A decade of changeNature Reviews Drug Discovery, 2012
- The productivity crisis in pharmaceutical R&DNature Reviews Drug Discovery, 2011
- The Discovery of Fluoxetine Hydrochloride (Prozac)Nature Reviews Drug Discovery, 2005
- Tumor necrosis factor as an antineoplastic agent: pitfalls and promisesCellular and Molecular Life Sciences, 1998
- A historical note on the development of zimelidine, the first selective serotonin reuptake inhibitorEuropean Psychiatry, 1996
- Cloning and expression of the human erythropoietin gene.Proceedings of the National Academy of Sciences, 1985
- Adrenergic and Cholinergic Receptors in the Human Prostate, Prostatic Capsule and Bladder NeckBritish Journal of Urology, 1975